Video-assisted Thyroid Surgery and Hypnosis in Thyroid Surgery

NCT ID: NCT01752283

Last Updated: 2012-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

130 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-01-31

Study Completion Date

2012-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is aimed to investigate the safety and feasibility of Video-assisted thyroidectomy under hypnosis in comparison to general anesthesia

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Summary of the project

video-assisted thyroidectomy (MIVAT): General anesthesia (GA) versus hypnosis (HY)

Investigators

Prof. Michel Mourad\*, Dr. Christine Watremez \*\*, Prof. Fabienne Roelants\*\*

\* Surgery and Abdominal Transplantation Division

\*\* Department of Anesthesiology,

Université Catholique de Louvain, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, 1200 Brussels, Belgium

1. Aim

The aim of this pilot study is to prospectively investigate, in a consecutive series of patients, the feasibility and safety of MIVAT under HY associated with local anesthesia, compared to GA.
2. Inclusion criteria

* Adult patients candidates to total or partial thyroidectomy.
* ASA 1, 2 or 3
* One surgeon (MM)
* Informed consent
3. Exclusion criteria

* Age \<18 years
* The presence of familial medullary thyroid cancers
* Suspicious or metastatic lymph nodes
* Redo surgery
* ASA 4 patients
* Patients with chronic pain
* Deaf people
* Patients with psychiatric diseases
* Known recurrent nerve paralysis
4. Outcome evaluation

* Primary outcomes: safety and feasibility.
* During surgery, considered events for analysis should include operating time (from skin incision to skin closure), total time in the operating room, intraoperative bleeding, drug consumption, Hemodynamic changes and conversion rates from MIVAT to a conventional approach and from HY to GA.
* After surgery, comparative variables for analysis should include: drug consumption, hospital stay, calcemia, and vocal cord abnormality on the basis of day-one laryngoscopy performed by an ENT doctor not involved in the study.
5. Patients selection and study groups:

Selection of patients for MIVAT is based on the size of the gland and nodules, provided that the craniocaudal axis of the lobes did not exceed 7cm and the largest transversal diameter was less than 3.5cm. All patients who are assigned to undergo MIVAT are instructed about the possibility of conversion to a conventional approach. The patients are left free to choose the type of anesthesia they prefere for their surgical intervention. They have to give informed consent before the procedure.

A. General anesthesia group:

Premedication:

* Lorazepam 0.5 mg 1 h before surgery
* ECG, NIBP, SaO2
* VVP + NaCl 0.9 % 500 mL + taradyl 0.5 mg / kg (\<30 mg)

Induction:

* Remifentanil 0.05 µg/kg/min
* Propofol 2 mg/kg
* Intubation with an armored endotracheal tube specially devised for neuromonitoring of the vocal cords.

During surgery:

* Sevoflurane / Remifentanil

B. Hypnosis group:

Premedication:

* Lorazepam 0.5 mg 1 h avant l'intervention
* ECG, NIBP, SaO2
* VVP + NaCl 0.9 % 500 mL + taradyl 0.5 mg / kg (\< 30 mg)

Induction and during surgery:

* Remifentanil modified as requested
* Induction of hypnosis according to Milton Eriksson technique
* Midazolam (titrated 0.1 mg/0.1mg) if needed as anxiolytic.
* Local anesthesia mixture (lidocaine 0.5%/ropivacaine 0.25%) to be administered by the surgeon along the incision line 5 minutes before making the skin incision.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgery

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Videoassited Thyroidectomy Minimal invasive surgery General anesthesia Hypnosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hypnosis and local anesthesia

video-assisted thyroidectomy under hypnosis and local anesthesia.

Group Type EXPERIMENTAL

video-assisted thyroidectomy

Intervention Type PROCEDURE

Experimental arm: video-assisted thyroidectomy under local anesthesia and hypnosis

Video-assisted thyroidectomy

Intervention Type PROCEDURE

video-assisted thyroidectomy under general anesthesia

General anesthesia

Video-assisted thyroidectomy under general anesthesia

Group Type ACTIVE_COMPARATOR

video-assisted thyroidectomy

Intervention Type PROCEDURE

Experimental arm: video-assisted thyroidectomy under local anesthesia and hypnosis

Video-assisted thyroidectomy

Intervention Type PROCEDURE

video-assisted thyroidectomy under general anesthesia

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

video-assisted thyroidectomy

Experimental arm: video-assisted thyroidectomy under local anesthesia and hypnosis

Intervention Type PROCEDURE

Video-assisted thyroidectomy

video-assisted thyroidectomy under general anesthesia

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The selection of patients for MIVAT was achieved according to the size of the gland and nodules provided that the cranio-caudal axis of the lobes does not exceed 7 centimeters and the largest transversal diameter is less than 3.5 centimeters
* Age \>18 years

Exclusion Criteria

* No previous neck surgery
* No known malignancy
* No history of neck irradiation
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mourad

MD, PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michel Mourad, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Cliniques Universitaires Saint-Luc. 10 Avenue Hippocrate, 10. 1200 Bruxelles

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cliniques Universitaires Saint-Luc. 10 Avenue Hippocrate

Brussels, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Video-Hypnose

Identifier Type: -

Identifier Source: org_study_id